• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齐考诺肽与精神病:从一例病例报告到一项范围综述

Ziconotide and psychosis: from a case report to a scoping review.

作者信息

Peraire Marc, Gimeno-Vergara Rita, Pick-Martin Jennifer, Boscá Mireia, Echeverria Iván

机构信息

TXP Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, Castellón de la Plana, Spain.

Department of Mental Health, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Spain.

出版信息

Front Mol Neurosci. 2024 Oct 16;17:1412855. doi: 10.3389/fnmol.2024.1412855. eCollection 2024.

DOI:10.3389/fnmol.2024.1412855
PMID:39479264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11523125/
Abstract

Ziconotide is a non-opioid analgesic that acts on N-type voltage-gated calcium channels. Despite its proven effectiveness in pain treatment, it can induce neuropsychiatric symptoms. The aim of this article is to present a case of psychosis secondary to ziconotide and to explore the variety of neuropsychiatric symptoms it produces, exploring the relationship between these symptoms and the mechanism of action of ziconotide. For this purpose, a clinical case is presented as well as a scoping review of other cases published in the scientific literature. A search on Web of Science, Pubmed and Embase databases was performed on December 11, 2023, following the criteria of the PRISMA-ScR Statement. The clinical case presented shows the variety of neuropsychiatric symptomatology that ziconotide can cause in the same patient. On the other hand, 13 papers were retrieved from the scoping review (9 case reports, 4 case series), which included 21 cases of patients treated with ziconotide who presented adverse effects ranging from psychotic symptoms to delirium. In conclusion, the variety of neuropsychiatric symptoms derived from ziconotide could be related to the blockade of N-type voltage-gated calcium channels in glutamatergic and GABAergic neurons, in turn affecting dopaminergic pathways.

摘要

齐考诺肽是一种作用于N型电压门控钙通道的非阿片类镇痛药。尽管其在疼痛治疗中的有效性已得到证实,但它可诱发神经精神症状。本文的目的是介绍一例继发于齐考诺肽的精神病病例,并探讨其产生的各种神经精神症状,探究这些症状与齐考诺肽作用机制之间的关系。为此,本文介绍了一个临床病例,并对科学文献中发表的其他病例进行了范围综述。按照PRISMA-ScR声明的标准,于2023年12月11日在科学网、PubMed和Embase数据库上进行了检索。所呈现的临床病例显示了齐考诺肽可在同一患者中引起的各种神经精神症状。另一方面,从范围综述中检索到13篇论文(9篇病例报告,4篇病例系列),其中包括21例接受齐考诺肽治疗的患者,这些患者出现了从精神症状到谵妄等不良反应。总之,齐考诺肽引起的各种神经精神症状可能与谷氨酸能和γ-氨基丁酸能神经元中N型电压门控钙通道的阻断有关,进而影响多巴胺能通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9acf/11523125/68c46860fde4/fnmol-17-1412855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9acf/11523125/68c46860fde4/fnmol-17-1412855-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9acf/11523125/68c46860fde4/fnmol-17-1412855-g001.jpg

相似文献

1
Ziconotide and psychosis: from a case report to a scoping review.齐考诺肽与精神病:从一例病例报告到一项范围综述
Front Mol Neurosci. 2024 Oct 16;17:1412855. doi: 10.3389/fnmol.2024.1412855. eCollection 2024.
2
Ziconotide-induced psychosis: A case report and literature review.齐考诺肽所致精神病:一例报告及文献综述。
Ment Health Clin. 2018 Aug 30;8(5):242-246. doi: 10.9740/mhc.2018.09.242. eCollection 2018 Sep.
3
Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.齐考诺肽——一种用于鞘内治疗重度慢性疼痛的新型神经元特异性钙通道阻滞剂——一篇简短综述。
Int J Clin Pharmacol Ther. 2006 Oct;44(10):478-83. doi: 10.5414/cpp44478.
4
Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.鞘内注射齐考诺肽:对其他全身或鞘内镇痛药物难治的慢性疼痛患者的应用评价。
CNS Drugs. 2013 Nov;27(11):989-1002. doi: 10.1007/s40263-013-0107-5.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Ziconotide: neuronal calcium channel blocker for treating severe chronic pain.齐考诺肽:用于治疗重度慢性疼痛的神经元钙通道阻滞剂。
Curr Med Chem. 2004 Dec;11(23):3029-40. doi: 10.2174/0929867043363884.
7
Do the potential benefits outweigh the risks? An update on the use of ziconotide in clinical practice.潜在的益处是否超过风险?齐考诺肽在临床实践中的应用更新。
Eur J Pain. 2018 Aug;22(7):1193-1202. doi: 10.1002/ejp.1229. Epub 2018 Apr 25.
8
Ziconotide-induced psychosis: a case report.齐考诺肽诱发的精神病:一例报告。
Gen Hosp Psychiatry. 2015 Jan-Feb;37(1):97.e11-2. doi: 10.1016/j.genhosppsych.2014.10.001. Epub 2014 Oct 13.
9
Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.鞘内注射齐考诺肽(一种神经元N型电压敏感性钙通道的选择性阻滞剂)与吗啡对大鼠痛觉感受的相互作用。
Pain. 2000 Feb;84(2-3):271-81. doi: 10.1016/s0304-3959(99)00214-6.
10
Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.齐考诺肽,一种新型N型钙通道阻滞剂,鞘内注射用于术后急性疼痛。
Reg Anesth Pain Med. 2000 May-Jun;25(3):274-8. doi: 10.1016/s1098-7339(00)90010-5.

本文引用的文献

1
Regulation of N-type calcium channels by nociceptin receptors and its possible role in neurological disorders.阿片胜肽受体对 N 型钙通道的调节及其在神经紊乱中的可能作用。
Mol Brain. 2022 Nov 24;15(1):95. doi: 10.1186/s13041-022-00982-z.
2
Proteomic biomarkers of Kleine-Levin syndrome.Kleine-Levin 综合征的蛋白质组生物标志物。
Sleep. 2022 Sep 8;45(9). doi: 10.1093/sleep/zsac097.
3
Kleine-Levin syndrome, GABA, and glutamate.克莱恩-莱文综合征、γ-氨基丁酸和谷氨酸。
J Clin Sleep Med. 2021 Mar 1;17(3):609-610. doi: 10.5664/jcsm.9058.
4
Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases.扎考必利诱导的口-舌运动障碍:3 例报告
Tremor Other Hyperkinet Mov (N Y). 2020 Oct 6;10:37. doi: 10.5334/tohm.431.
5
The Cannabinoid CB Receptor in Schizophrenia.精神分裂症中的大麻素 CB 受体。
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Jun;6(6):646-659. doi: 10.1016/j.bpsc.2020.06.018. Epub 2020 Jul 6.
6
Genetic Associations between Voltage-Gated Calcium Channels and Psychiatric Disorders.电压门控钙通道与精神障碍的遗传关联。
Int J Mol Sci. 2019 Jul 19;20(14):3537. doi: 10.3390/ijms20143537.
7
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments.抑郁症中的连接改变:新型治疗方法对 GABA 和谷氨酸神经递质缺陷的影响及逆转。
Neuron. 2019 Apr 3;102(1):75-90. doi: 10.1016/j.neuron.2019.03.013.
8
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.谷氨酸能神经代谢物在重度抑郁症中的水平:质子磁共振波谱研究的系统评价和荟萃分析。
Mol Psychiatry. 2019 Jul;24(7):952-964. doi: 10.1038/s41380-018-0252-9. Epub 2018 Oct 12.
9
Ziconotide-induced psychosis: A case report and literature review.齐考诺肽所致精神病:一例报告及文献综述。
Ment Health Clin. 2018 Aug 30;8(5):242-246. doi: 10.9740/mhc.2018.09.242. eCollection 2018 Sep.
10
Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia.氯胺酮依赖伴持续性精神病与精神分裂症的类似精神病和认知特征。
Schizophr Res. 2018 Sep;199:313-318. doi: 10.1016/j.schres.2018.02.049. Epub 2018 Mar 3.